Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Gymnadenia conopsea
European terrestrial orchid used in traditional Alpine medicine as a tonic and aphrodisiac.
Gymnadenia conopsea, a European terrestrial orchid, is traditionally used in Alpine medicine as a tonic and aphrodisiac. Modern research suggests adaptogenic and digestive-supportive properties, attributed to compounds such as loroglossin, glucomannans, and phenanthrenes. Evidence remains limited (Grade C), primarily from traditional use and preliminary studies.
Loroglossin, a bitter glycoside, may stimulate digestive secretions via activation of bitter taste receptors (TAS2Rs) in the gut, enhancing gastric motility and appetite. Glucomannans form a viscous gel that modulates intestinal transit and prebiotic activity. Phenanthrenes exhibit mild antioxidant and anti-inflammatory effects through inhibition of COX-2 and NF-κB pathways. Adaptogenic effects are hypothesized via modulation of the HPA axis, but specific receptor interactions are not well characterized.
European terrestrial orchid used in traditional Alpine medicine as a tonic and aphrodisiac.
Gymnadenia conopsea, a European terrestrial orchid, is traditionally used in Alpine medicine as a tonic and aphrodisiac. Modern research suggests adaptogenic and digestive-supportive properties, attributed to compounds such as loroglossin, glucomannans, and phenanthrenes. Evidence remains limited (Grade C), primarily from traditional use and preliminary studies.
Loroglossin, a bitter glycoside, may stimulate digestive secretions via activation of bitter taste receptors (TAS2Rs) in the gut, enhancing gastric motility and appetite. Glucomannans form a viscous gel that modulates intestinal transit and prebiotic activity. Phenanthrenes exhibit mild antioxidant and anti-inflammatory effects through inhibition of COX-2 and NF-κB pathways. Adaptogenic effects are hypothesized via modulation of the HPA axis, but specific receptor interactions are not well characterized.